A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...
Not to mention paying out of pocket if you don't have vision insurance. Eyebot, an AI-powered health tech company, wants to ...
IHealthScreen hauled in FDA 510(k) clearance for its AI-powered diagnostic that detects mild diabetic retinopathy in diabetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results